pCPA

All the posts published.

CADTH Pharmaceutical Reviews Update – July 2019

August 16, 2019
-
Market Access News
-
Posted by MORSE Team
Read More →
Read More →

pCPA Closing More Negotiations Without Agreements

August 6, 2019
-
Market Access News
-
Posted by MORSE Team
Read More →
Read More →

Number of Active Negotiations (49) at Highest Level Since November 2018

July 7, 2019
-
Market Access News
-
Posted by MORSE Team
Read More →
Read More →

The pCPA Initiates Negotiations for a Second “Group” of Oncology Biosimilars

June 18, 2019
-
Market Access News
-
Posted by MORSE Team
Read More →
Read More →

April 2019 pCPA Update: The pCPA has completed over 250 negotiations

May 14, 2019
-
Market Access News
-
Posted by MORSE Team
Read More →
Read More →

March 2019 pCPA Update: Two negotiations initiated prior to completion of CADTH process

April 8, 2019
-
Market Access News
-
Posted by MORSE Team
Read More →
Read More →

pCPA Trends and Insights – Two Biosimilars Initiated Negotiations and Two Multi-Indication Negotiations were Completed

March 15, 2019
-
Market Access News
-
Posted by MORSE Team
Read More →
Read More →

MORSE Consulting Releases its 2018 pCPA Year in Review Infographic

March 7, 2019
-
Market Access News, Publications
-
Posted by MORSE Team
Read More →
Read More →

pCPA Negotiation Status Update January 2019 – Two Oncology Negotiations Closed without LOI

February 14, 2019
-
Market Access News
-
Posted by MORSE Team
Read More →
Read More →

Spotlight on the Atlantic Provinces: pCPA Letter of Intent Conversion and Time-to-Listing Analysis

January 24, 2019
-
Market Access News, Publications
-
Posted by MORSE Team
Read More →
Read More →

pCPA Process Timelines Highlights – A Year-in-Review Primer

January 15, 2019
-
Market Access News
-
Posted by MORSE Team
Read More →
Read More →

pCPA Complete its Most Active Month by Adjudicating 15 Files in November

December 20, 2018
-
Market Access News
-
Posted by MORSE Team
Read More →
Read More →

BC Pharmacare Now Transitioning Patients on Copaxone® to GLATECT™

November 29, 2018
-
Market Access News
-
Posted by MORSE Team
Read More →
Read More →

Number of Active pCPA Negotiations at an All-Time High and Continues to Climb

November 19, 2018
-
Market Access News
-
Posted by MORSE Team
Read More →
Read More →

Significant Developments in Canadian Drugs for Rare Disease Policy

November 14, 2018
-
Market Access News
-
Posted by MORSE Team
Read More →
Read More →
pCPA - Info and details on - Page 4 of 7 - MORSE Consulting Inc.